Your browser doesn't support javascript.
loading
Extracellular Vesicles in Chronic Obstructive Pulmonary Disease.
Kadota, Tsukasa; Fujita, Yu; Yoshioka, Yusuke; Araya, Jun; Kuwano, Kazuyoshi; Ochiya, Takahiro.
Afiliação
  • Kadota T; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo 104-0045, Japan. tskadota@ncc.go.jp.
  • Fujita Y; Division of Respiratory Disease, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan. tskadota@ncc.go.jp.
  • Yoshioka Y; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo 104-0045, Japan. yuugot@gmail.com.
  • Araya J; Division of Respiratory Disease, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan. yuugot@gmail.com.
  • Kuwano K; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo 104-0045, Japan. yyoshiok@ncc.go.jp.
  • Ochiya T; Division of Respiratory Disease, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan. araya@jikei.ac.jp.
Int J Mol Sci ; 17(11)2016 Oct 27.
Article em En | MEDLINE | ID: mdl-27801806
ABSTRACT
Chronic obstructive pulmonary disease (COPD) is characterized by the progression of irreversible airflow limitation and is a leading cause of morbidity and mortality worldwide. Although several crucial mechanisms of COPD pathogenesis have been studied, the precise mechanism remains unknown. Extracellular vesicles (EVs), including exosomes, microvesicles, and apoptotic bodies, are released from almost all cell types and are recognized as novel cell-cell communication tools. They have been shown to carry and transfer a wide variety of molecules, such as microRNAs, messenger RNAs, and proteins, which are involved in physiological functions and the pathology of various diseases. Recently, EVs have attracted considerable attention in pulmonary research. In this review, we summarize the recent findings of EV-mediated COPD pathogenesis. We also discuss the potential clinical usefulness of EVs as biomarkers and therapeutic agents for the treatment of COPD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Micropartículas Derivadas de Células / Vesículas Extracelulares Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Micropartículas Derivadas de Células / Vesículas Extracelulares Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article